GPs need better training to improve outcomes for patients with psoriasis

May 1, 2014

GPs need enhanced training to help them to manage patients with the complex, long term condition psoriasis which affects 1.8 million people in the UK, experts from The University of Manchester argue.

Psoriasis can affect anyone and is reported to affect celebrities including Alan Carr and model Cara Delevingne. But often it is a hidden condition.

The inflammatory skin condition is also associated with heart disease, depression and other inflammatory conditions such as Crohn's disease and arthritis.

But research shows even doctors specialising in skin care receive very little training about how to manage psoriasis as a long-term condition with the effects that this condition can have on all aspects of life. As well as the other medical conditions associated with psoriasis, smoking, being overweight, inactivity and excess alcohol use much more common in people with psoriasis and affect flares but patients rarely receive adequate support to make lifestyle changes.

Dr Christine Bundy, one of the theme leads on the National Institute for Health Research (NIHR)-funded Identification and Management of Psoriasis Associated ComorbidiTy (IMPACT) research programme, is involved in the launch of a new training programme for practitioners aiming to improve health outcomes for their patients with psoriasis. This training will officially be launched in Manchester on Thursday 1 May.

Dr Bundy said: "Our research shows in addition to the presence of cardiovascular disease, patients often also have low mood and this impacts on motivation to self-manage psoriasis. In addition, we have reports that most clinicians, even those with a special interest in psoriasis, do not feel skilled or confident in supporting patients to change their lifestyle behaviour to help manage their condition better yet we know evidence based methods to manage mood and behaviour can improve quality of life and help people recover from psoriasis flares quicker.

"Not identifying these additional factors which are often associated with psoriasis is not only bad news for the patients it also has financial implications for the future health spend in the NHS."

Clinicians who do want training in how to support patients often do not have access to a quality assured, relevant and tailored programme to enable them to develop and practice the necessary skills, researchers say. Some are able to attend, usually industry sponsored, training events but access to those events is restricted and the opportunities are ad hoc and not part of any established or accredited programme of continuing professional development.

The world-renowned team from the University of Manchester and Salford Royal NHS Foundation Trust is now launching a pilot programme to better train clinicians in the North West which, if successful, they hope could be rolled out on a larger scale.

Set to train GPs and medics over the next six months, it will involve helping practitioners develop their skills in the management of psoriasis as a long term condition with particular emphasis on supporting motivation to make lifestyle, behaviour changes.

Professor Chris Griffiths, consultant dermatologist at Salford Royal NHS Foundation Trust and IMPACT Principal Investigator, added: "We've looked at the barriers doctors face in treating the patient for all their symptoms.

"A large part of our training will focus on how to have the conversations that can make a difference to people's lives such as noticing whether their psoriasis is affecting other areas of their life for example drinking too much, over-eating, being inactive or feeling low and depressed.

"There's often time pressures in a 10 minute consultation but these techniques are not about adding to doctors' workloads but setting on the right pathway of treatments and lifestyle changes earlier so that they spend fewer years in the wilderness with their psoriasis being treated inadequately."

A survey of some medics questioned about current training highlighted they believe it is insufficient in general and especially inadequate to manage unhealthy behaviour". Another admitted to confusion and said: "I thought of psoriasis primarily as a skin complaint. I am aware that there are systematic problems but I sometimes find it difficult to put the two together".

Patients however reported a need for doctors to recognise that psoriasis was more than a skin complaint. One said: "It's a skin condition but it goes beyond that, it sort of runs deeply…it got to the stage where I was thinking about it so much I actually cancelled meeting my friends. Toby Hadoke, a London-based comedian with psoriasis, said: "It took 25 years for a clinician to say to me, we can manage your and the impact it has on your life, that was a lifeline for me."

Explore further: Largest clinical trial for potential new psoriasis treatment

Related Stories

Largest clinical trial for potential new psoriasis treatment

December 10, 2013
Novartis Pharmaceuticals UK has announced the launch of the UK's largest clinical trial to investigate a potential new biologic treatment for adults with moderate-severe psoriasis.

Skin care tips for psoriasis patients

August 25, 2013
(HealthDay)—Sun protection is among the skin care habits that can help people with the chronic skin condition psoriasis reduce some of the discomfort they may experience, such as skin itching, cracking and bleeding, an ...

Psoriasis patients should be screened for CVD

October 29, 2013
World Psoriasis Day is held today with the theme "Global access to treatment" to highlight the fact that more than 125 million people have psoriasis but not all have access to treatment. Early and effective therapy lessens ...

Steroids often prescribed for psoriasis, countering guidelines

March 3, 2014
(HealthDay News)—Although corticosteroid pills are not recommended for the management of psoriasis, new research reveals these drugs are commonly prescribed by dermatologists treating this chronic skin condition.

New target for psoriasis treatment discovered

February 12, 2014
Researchers at King's College London have identified a new gene (PIM1), which could be an effective target for innovative treatments and therapies for the human autoimmune disease, psoriasis.

Psoriasis increases risk of diabetes: study

June 18, 2012
Psoriasis is an independent risk for Type 2 Diabetes, according to a new study by researchers with the Perelman School of Medicine at the University of Pennsylvania, with the greatest risk seen in patients with severe psoriasis. ...

Recommended for you

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.